Skip To Main Content
Inc. Palo Alto on Muck Rack

Inc. Palo Alto

As seen in: Color Research & Application, RXLIST®
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Inc. Palo

Contact Inc. Palo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Side Effects, Uses, Dosage, Interactions, Warnings

|
By John P. Cunha, Inc. Palo Alto
| RXLIST®
What Is Epidiolex? Epidiolex (cannabidiol) oral solution, CX is a plant-derived cannabidiol (CBD) antiepileptic drug (AED) indicated for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. What Are Side Effects of Epidiolex?
Open in Who Shared Issue with article?

Side Effects, Uses, Dosage, Interactions, Warnings

|
By John P. Cunha, Inc. Palo Alto
| RXLIST®
Description for Zepzelca ZEPZELCA is an alkylating drug. The chemical name of ZEPZELCA (lurbinectedin) is (1’R,6R,6aR,7R,13S,14S,16R)-8,14-dihydroxy-6’,9-dimethoxy-4,10,23-trimethyl-19-oxo9 2’,3’,4’,6,7,9’,12,13,14,16-decahydro-6aH-spiro[7,13-azano-6,16-(epithiopropanooxymethano) [1,3]dioxolo[7,8]isoquinolino[3,2-b][3]benzazocine-20,1’-pyrido[3,4-b]indol]-5-yl acetate. The molecular formula is C41H44N4O10S.
Open in Who Shared Issue with article?

Side Effects, Uses, Dosage, Interactions, Warnings

|
By Inc. Palo Alto
| RXLIST®
WARNING CENTRAL NERVOUS SYSTEM DEPRESSION and ABUSE AND MISUSE. Central Nervous System Depression XYWAV is a CNS depressant. Clinically significant respiratory depression and obtundation may occur in patients treated with XYWAV at recommended doses [see WARNINGS AND PRECAUTIONS]. Many patients who received XYWAV during clinical trials in narcolepsy were receiving central nervous system stimulants [see Clinical Trials].
Open in Who Shared Issue with article?
See all 8 articles